nature immunology: doi:10.1038/ni · smoke-exposed wild-type lung apcs are sufficient to induce...

8
Supplementary Figure 1 miR-22 is required for airway MMP activities but not for the development of γδ + T cells in emphysema. (a) Gelatin zymogram depicting matrix metalloproteinase (MMP) 2 and MMP9 activities in bronchoalveolar lavage fluid (BALF) of wild type (WT; lanes 3-5) and Mir22 –/– mice (lanes 6-9) previously challenged with nCB. Lanes 1 and 2 are BALF from naïve wild type mice. (b) Total lung IL-17A+ γδ+ T cells were quantified by flow cytometry. Nature Immunology: doi:10.1038/ni.3292

Upload: vucong

Post on 17-Jul-2019

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Nature Immunology: doi:10.1038/ni · Smoke-exposed wild-type lung APCs are sufficient to induce emphysema in mice with and without miR-22. Lung CD11c+ APC from four month cigarette

Supplementary Figure 1

miR-22 is required for airway MMP activities but not for the development of γδ+ T cells in emphysema.

(a) Gelatin zymogram depicting matrix metalloproteinase (MMP) 2 and MMP9 activities in bronchoalveolar lavage fluid (BALF) of wild type (WT; lanes 3-5) and Mir22–/– mice (lanes 6-9) previously challenged with nCB. Lanes 1 and 2 are BALF from naïve wild type mice. (b) Total lung IL-17A+ γδ+ T cells were quantified by flow cytometry.

Nature Immunology: doi:10.1038/ni.3292

Page 2: Nature Immunology: doi:10.1038/ni · Smoke-exposed wild-type lung APCs are sufficient to induce emphysema in mice with and without miR-22. Lung CD11c+ APC from four month cigarette

Supplementary Figure 2

Mir22–/– mice develop reduced TH17 responses upon sensitization with ovalbumin.

Both WT and Mir22–/– mice were intraperitoneally injected with 25µg ovalbumin precipitated in alum weekly for three consecutive weeks. Total splenocytes were harvested at the end of the fifth week. (a) IFN-γ, (b) IL-4 and (c) IL-17A positive cells with ovalbumin (OVA; 0.5 mg/ml overnight) and without (Media) were quantified by ELISpot. *: p<0.05, Kruskal Wallis test. n=4.

Nature Immunology: doi:10.1038/ni.3292

Page 3: Nature Immunology: doi:10.1038/ni · Smoke-exposed wild-type lung APCs are sufficient to induce emphysema in mice with and without miR-22. Lung CD11c+ APC from four month cigarette

Supplementary Figure 3

nCB-induced production of pro-inflammatory cytokines and chemokines from whole lung is in part miR-22 dependent.

WT and Mir22–/– mice were challenged intranasally with nCB over one month. (a-d) Lungs were then collected and the concentrations of the indicated cytokines and chemokines from lung homogenate fluids were determined by Bio-plex. (e-g) Lung CD11c+ cells were isolated and cultured ex vivo overnight. Concentrations of the indicated supernatant chemokines were determined by Bio-plex. *: p<0.05; **: p<0.01, ***: p<0.001, Kruskal Wallis test. n=4-5.

Nature Immunology: doi:10.1038/ni.3292

Page 4: Nature Immunology: doi:10.1038/ni · Smoke-exposed wild-type lung APCs are sufficient to induce emphysema in mice with and without miR-22. Lung CD11c+ APC from four month cigarette

Supplementary Figure 4

Smoke-exposed wild-type lung APCs are sufficient to induce emphysema in mice with and without miR-22.

Lung CD11c+ APC from four month cigarette SMK or air exposed WT mice were isolated and adaptively transferred to WT and Mir22–/– recipients. (a) Micro-CT quantification of recipient mouse lung volume after 3 months. (b) Total macrophages in BALF. (c) Relative abundance of lung IL-17A+ TH17 cells as assessed by flow cytometry. *: p<0.05; **: p<0.01, Kruskal Wallis test. n=3-4 as indicated in (A).

Nature Immunology: doi:10.1038/ni.3292

Page 5: Nature Immunology: doi:10.1038/ni · Smoke-exposed wild-type lung APCs are sufficient to induce emphysema in mice with and without miR-22. Lung CD11c+ APC from four month cigarette

Supplementary Figure 5

PPAR-γ regulates miR-22 expression in lung APCs.

(a) MiR-22 expression in CD11c+ lung APCs from eight month old Ppargflox and PpargCD11c mice. (b) MiR-22 expression in CD11c+ lung APCs from air or cigarette smoke (SMK) exposed mice with or without intranasally challenge of ciglitazone (Cig). *: p<0.05; unpaired t-test in (a) one-way ANOVA test in (b). (n=3)

Nature Immunology: doi:10.1038/ni.3292

Page 6: Nature Immunology: doi:10.1038/ni · Smoke-exposed wild-type lung APCs are sufficient to induce emphysema in mice with and without miR-22. Lung CD11c+ APC from four month cigarette

Supplementary Figure 6

miR-22 is required for pro-inflammatory gene expression in nCB-exposed lung APCs.

Lung CD11c+ cells from WT and Mir22–/– mice exposed to PBS or nCB were isolated. Expression of indicated genes was determined by quantitative PCR. *, p<0.05; **, p<0.01; ***, p<0.001, One-way ANOVA test. (n=3)

Nature Immunology: doi:10.1038/ni.3292

Page 7: Nature Immunology: doi:10.1038/ni · Smoke-exposed wild-type lung APCs are sufficient to induce emphysema in mice with and without miR-22. Lung CD11c+ APC from four month cigarette

Supplementary Figure 7

miR-22 deficient APCs induce a TH17 cytokine in vitro with supplementation of IL-6.

MiR-22 sufficient (Mir22flox) and deficient BMDCs (Mir22CD11c) were primed with or without 1000ng nCB and co-cultured with WT naïve CD4+ T cells for 3 days and secreted IL-17A was measured by ELISA (n=4-5). 10ng/ml IL-6 supplement was added as indicated. *: p<0.05; Mann-Whitney test (n=4-5).

Nature Immunology: doi:10.1038/ni.3292

Page 8: Nature Immunology: doi:10.1038/ni · Smoke-exposed wild-type lung APCs are sufficient to induce emphysema in mice with and without miR-22. Lung CD11c+ APC from four month cigarette

Supplementary Figure 8

Silencing miR-22 alters pro- and anti-inflammatory gene expression in APCs.

Mice were sacrificed at the 5 month point in Figure (8a). (a) MiR-22 expression level in lung CD11c+ cells. IL-6 (b) and IL-17A (c) concentration in lung homogenates as assessed by Bioplex. (d-f) Indicated gene expression in isolated lung CD11c+ cells determined by RT-qPCR. *, p<0.05; **, p<0.01; ***, p<0.001, Kruskal Wallis test (n=4-6). Data in are from one of two comparable experiments.

Nature Immunology: doi:10.1038/ni.3292